We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
(-8%)
Cap. Flow
-$1.7B
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$219M |
| 2 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$185M |
| 3 |
Ross Stores
ROST
|
+$144M |
| 4 |
Progressive
PGR
|
+$134M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.49B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$762M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$476M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$348M |
| 5 |
Archer Daniels Midland
ADM
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.9% |
| 2 | Industrials | 13.89% |
| 3 | Financials | 12.91% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
BioMarin Pharmaceuticals
BMRN
$12.4B
| $58M | 0.06% |
713,316
-23,155
| -3% | -$1.94M |
|
452
CryoPort
CYRX
$762M
| $57.6M | 0.06% |
1,661,069
+374,045
| +29% | +$14.1M |
|
453
BioCryst Pharmaceuticals
BCRX
$2.4B
| $57.5M | 0.06% |
3,553,521
+3,112,255
| +705% | +$49.9M |
|
454
Sotera Health
SHC
$5.38B
| $57.5M | 0.06% |
2,653,434
+138,909
| +6% | +$2.95M |
|
455
SPDR Gold Trust
GLD
$142B
| $57.4M | 0.06% |
324,205
+254,149
| +363% | +$44.6M |
|
456
Columbus McKinnon
CMCO
$584M
| $57.3M | 0.06% |
1,352,692
+34,398
| +3% | +$1.55M |
|
457
Wingstop
WING
$3.18B
| $57.3M | 0.06% |
489,599
-6,074
| -1% | -$861K |
|
458
WEC Energy
WEC
$35.1B
| $57.2M | 0.06% |
571,631
+192,663
| +51% | +$18.2M |
|
459
Salesforce
CRM
$158B
| $56.9M | 0.06% |
323,425
+34,271
| +12% | +$7.38M |
|
|
ITCI
460
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $56.9M | 0.06% |
+932,322
| New | +$48.4M |
|
461
Littelfuse
LFUS
$11.6B
| $56.9M | 0.06% |
228,493
+54,360
| +31% | +$14.4M |
|
462
VICI Properties
VICI
$29.4B
| $56.9M | 0.06% |
1,941,702
+113,263
| +6% | +$3.18M |
|
|
EXE
463
Expand Energy Corp
EXE
$21.5B
| $56.9M | 0.06% |
654,532
-38,798
| -6% | -$2.85M |
|
464
CME Group
CME
$94.8B
| $56.7M | 0.06% |
258,659
+38,294
| +17% | +$8.99M |
|
465
CrowdStrike
CRWD
$218B
| $56.6M | 0.06% |
1,051,480
-816,552
| -44% | -$38M |
|
466
Ameren
AEE
$30.1B
| $56.3M | 0.06% |
606,201
+441,626
| +268% | +$38.7M |
|
467
Helen of Troy
HELE
$693M
| $56.2M | 0.06% |
286,528
-63,016
| -18% | -$13.3M |
|
468
Intuitive Surgical
ISRG
$134B
| $56.2M | 0.06% |
234,653
-8,723
| -4% | -$2.55M |
|
|
CNR
469
Core Natural Resources Inc
CNR
$4.45B
| $56.1M | 0.06% |
1,484,789
-234,201
| -14% | -$6.79M |
|
|
IPG
470
DELISTED
Interpublic Group of Companies
IPG
| $56M | 0.06% |
1,717,206
-4,333,580
| -72% | -$156M |
|
471
CoStar Group
CSGP
$12.3B
| $56M | 0.06% |
852,570
-242,298
| -22% | -$16.1M |
|
472
Analog Devices
ADI
$190B
| $55.6M | 0.06% |
360,096
+15,037
| +4% | +$2.44M |
|
473
Dynatrace
DT
$14.2B
| $55.4M | 0.06% |
1,190,868
-47,763
| -4% | -$2.25M |
|
474
Fair Isaac
FICO
$22.5B
| $55.3M | 0.06% |
129,535
-74,794
| -37% | -$35.3M |
|
475
CMS Energy
CMS
$22.3B
| $55.2M | 0.06% |
804,203
+259,642
| +48% | +$16.8M |
|
Similar funds
VGA
Victory Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.
- Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
- Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
- Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
- Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
- Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
- Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
- Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.
Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.